Clinical Trial Update: Pilot Phase III Clinical Trial of JDP-205 IV Injection for Treatment of Acute Urticaria [Phase 3]

View source ↗

Summary

Pilot Phase III trial of JDP-205 IV injection for acute urticaria has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urticaria

Drugs mentioned

• JDP-205

Snippet

Sponsor: JDP Therapeutics, Inc. | Conditions: Acute Urticaria | Phase 3 | Status: COMPLETED | Results posted: 2024-02-09